UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056129
Receipt number R000064134
Scientific Title An intervention study to assess efficiency of a new asthma control questionnaire for elderly asthma
Date of disclosure of the study information 2024/11/12
Last modified on 2024/11/12 14:05:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An intervention study to assess efficiency of a new asthma control questionnaire for elderly asthma

Acronym

efficiency of a new asthma control questionnaire for elderly asthma

Scientific Title

An intervention study to assess efficiency of a new asthma control questionnaire for elderly asthma

Scientific Title:Acronym

efficiency of a new asthma control questionnaire for elderly asthma

Region

Japan


Condition

Condition

asthma

Classification by specialty

Medicine in general Pneumology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the validity and usefulness of a newly developed asthma questionnaire for the elderly in daily clinical practice, and to assess life functions, including physical activity and cognitive function, in elderly asthma.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Asthma-related quality of life (AQLQ) before and after use of the new questionnaire

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

new questionnaire

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients shall meet all of the following criteria.
(1) Asthmatic patients aged 65 years or older who have been attending the study institution for at least one year
(2) Patients on GINA treatment steps 3, 4 and 5 at the time of enrolment
(3) Patients with information on treatment/medication in the last year prior to enrolment
(4) Patients with information on the number of acute asthma exacerbations, hospital admissions for asthma and unscheduled visits for asthma in the last year prior to registration
(5) Patients who have given their free written consent.

Key exclusion criteria

Patients who fall into any of the following categories shall not be included in the study.
(1) Patients with chronic respiratory diseases other than asthma/COPD
(2) Patients with a history of surgery/disease that would affect the physiological function tests
(3) Patients with psychiatric/neurological disorders or physical dysfunctions that may affect the questionnaire
(4) Other patients deemed inappropriate by the principal investigator/contributor.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Maho
Middle name
Last name Suzukawa

Organization

National Hospital Organization Tokyo National Hospital

Division name

Clinical Research Center

Zip code

2048585

Address

3-1-1 Takeoka, Kiyose-Shi, Tokyo, Japan

TEL

+81-42-491-2111

Email

fueta-tky@umin.ac.jp


Public contact

Name of contact person

1st name Maho
Middle name
Last name Suzukawa

Organization

National Hospital Organization Tokyo National Hospital

Division name

Clinical Research Center

Zip code

2048585

Address

3-1-1 Takeoka, Kiyose-Shi, Tokyo, Japan

TEL

+81-42-491-2111

Homepage URL


Email

fueta-tky@umin.ac.jp


Sponsor or person

Institute

National Hospital Organization Tokyo National Hospital

Institute

Department

Personal name



Funding Source

Organization

Environmental Restoration and Conservation Agency of Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organisation Nagoya Medical Center

Address

4-1-1, Sanomaru, Naka-ku, Nagoya, Aichi, Japan

Tel

+81-52-951-1111

Email

311-rec@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 07 Month 18 Day

Date of IRB

2024 Year 07 Month 18 Day

Anticipated trial start date

2024 Year 10 Month 01 Day

Last follow-up date

2026 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 12 Day

Last modified on

2024 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064134